Financials in USD. Standardized financial statements.
A compact view of how Thermo Fisher Scientific Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $44.56B | $42.88B | $42.86B | $44.91B | $39.21B | $32.22B | $25.54B | $24.36B | $20.92B | $18.27B |
| Revenue Growth? | +3.9% | +0.1% | -4.6% | +14.5% | +21.7% | +26.1% | +4.9% | +16.4% | +14.5% | 0.0% |
| Cost of Revenue? | $27.78B | $25.15B | $25.66B | $25.90B | $19.58B | $16.19B | $14.20B | $13.37B | $11.24B | $9.69B |
| Gross Profit? | $16.78B | $17.73B | $17.19B | $19.01B | $19.63B | $16.03B | $11.34B | $10.99B | $9.68B | $8.58B |
| Gross Margin? | +37.7% | +41.3% | +40.1% | +42.3% | +50.1% | +49.7% | +44.4% | +45.1% | +46.3% | +47.0% |
| Operating Expenses? | $8.67B | $10.07B | $9.75B | $10.49B | $9.32B | $8.13B | $7.08B | $7.12B | $6.41B | $5.72B |
| Operating Income? | $8.11B | $7.66B | $7.45B | $8.53B | $10.32B | $7.90B | $4.26B | $3.87B | $3.27B | $2.86B |
| EBITDA? | $11.47B | $11.80B | $11.20B | $11.94B | $11.97B | $10.11B | $7.02B | $6.20B | $5.05B | $4.25B |
| Income Before Tax | $7.27B | $7.00B | $6.24B | $7.66B | $8.84B | $7.23B | $4.07B | $3.26B | $2.43B | $2.02B |
| Income Tax Expense | $547.00M | $657.00M | $284.00M | $703.00M | $1.11B | $850.00M | $374.00M | $324.00M | $201.00M | -$1.40M |
| Net Income? | $6.74B | $6.33B | $6.00B | $6.95B | $7.72B | $6.38B | $3.70B | $2.94B | $2.23B | $2.02B |
| EPS? | $17.77 | $16.58 | $15.53 | $17.73 | $19.61 | $16.10 | $9.24 | $7.31 | $5.64 | $5.12 |
| Diluted EPS? | $17.74 | $16.53 | $15.45 | $17.64 | $19.46 | $15.98 | $9.17 | $7.24 | $5.59 | $5.09 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality